Archives

@kiranshaw @vijaygajera @vishalRanaaaa @manishagra

@kiranshaw @vijaygajera @vishalRanaaaa @manishagrawal7 @centerofright Even when these ‘opinions’ are blatant lies a… https://t.co/RJE8gePYXV

@DocCapital @jaynemil55 @JohnCendpts @JSully27 Sar

@DocCapital @jaynemil55 @JohnCendpts @JSully27 Sarilumab, IIRC, flunked its own covid trial. So difficult to use he… https://t.co/FJ7hncCxq5

Gary Lyman, MD, MPH, an #oncologist and #hematolog

Gary Lyman, MD, MPH, an #oncologist and #hematologist, discusses some of the issues holding physicians back from pr… https://t.co/PHCdaQ7ZUs

IandI Field Medical, Xeljanz/Biosimilars Outcomes

IandI Field Medical, Xeljanz/Biosimilars Outcomes and Analytics Director (MD/DO) – Remote, New York – Pfizer https://t.co/MlnWRT5foA

Biosimilars versus biologics: Is marketing madness

Biosimilars versus biologics: Is marketing madness on the way as biosimilar approvals balloon?… https://t.co/WbpnLBxh0m

IandI Field Medical, Xeljanz/Biosimilars Outcomes

IandI Field Medical, Xeljanz/Biosimilars Outcomes and Analytics Director (non-MD) – Remote, New York – Pfizer https://t.co/k2AN21ndgV

@JohnCendpts @JSully27 Any approved actemra biosim

@JohnCendpts @JSully27 Any approved actemra biosimilars out there? They should get emergency authorization to sell… https://t.co/L1Km27pGP6

Biologics, including biosimilars, are manufactured

Biologics, including biosimilars, are manufactured using living cells engineered to produce therapeutic proteins in… https://t.co/2iu7zibXhr

Daily Updates on Generic Entry, Litigation, Biosim

Daily Updates on Generic Entry, Litigation, Biosimilars, and more with the DrugPatentWatch Daily Briefing. Sign up… https://t.co/LTg4VS2vg0